AKAN
Akanda Corp.
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · GB
$3.35
−8.72%Price chart
Aug 6Aug 11Aug 14Aug 19Aug 24Aug 27Sep 1Sep 4
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
−1.8x
Market Cap
$1.81M
MomentumView details →
1D Return
−8.72%
YTD Return
−58.19%
RSI (14)
37.1
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
−1.8x
Market Cap
$1.81M
RSI (14)
37.1
MomentumView details →
1D Return
−8.72%
YTD Return
−58.19%
SummaryUpdated Dec 1, 2025
Akanda Corp. (NASDAQ:AKAN) is a cannabis cultivation, manufacturing, and distribution company founded in 2021 and headquartered in New Romney, United Kingdom. The company went public in March 2022 and operates primarily in the United Kingdom and Lesotho, focusing on the production and distribution of medical cannabis and wellness products. Since its inception, Akanda has been working to establish itself in the emerging global medical cannabis market, though it has faced significant operational and financial challenges in its early years as a public company.
Similar companies
Latest newsMore news →
Akanda Corp.'s subsidiary First Towers & Fiber Corp. delivered an operational and expansion update on Friday.21d agoAkanda Corp.'s subsidiary First Towers & Fiber Corp. completed a 200 km fiber network in Mexico, increasing recurring revenue.22d agoAkanda Corp. received a Nasdaq notice for non-compliance with the minimum stockholders' equity requirement.78d ago